201 related articles for article (PubMed ID: 32508363)
21. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
Kemp DE; Gao K; Ganocy SJ; Elhaj O; Bilali SR; Conroy C; Findling RL; Calabrese JR
J Clin Psychiatry; 2009 Jan; 70(1):113-21. PubMed ID: 19192457
[TBL] [Abstract][Full Text] [Related]
22. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
23. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
Suppes T; Vieta E; Gustafsson U; Ekholm B
Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
[TBL] [Abstract][Full Text] [Related]
24. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.
Nierenberg AA; McElroy SL; Friedman ES; Ketter TA; Shelton RC; Deckersbach T; McInnis MG; Bowden CL; Tohen M; Kocsis JH; Calabrese JR; Kinrys G; Bobo WV; Singh V; Kamali M; Kemp D; Brody B; Reilly-Harrington NA; Sylvia LG; Shesler LW; Bernstein EE; Schoenfeld D; Rabideau DJ; Leon AC; Faraone S; Thase ME
J Clin Psychiatry; 2016 Jan; 77(1):90-9. PubMed ID: 26845264
[TBL] [Abstract][Full Text] [Related]
25. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
Suppes T; Vieta E; Liu S; Brecher M; Paulsson B;
Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454
[TBL] [Abstract][Full Text] [Related]
26. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.
Calabrese JR; Shelton MD; Rapport DJ; Youngstrom EA; Jackson K; Bilali S; Ganocy SJ; Findling RL
Am J Psychiatry; 2005 Nov; 162(11):2152-61. PubMed ID: 16263857
[TBL] [Abstract][Full Text] [Related]
27. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.
Sachs G; Chengappa KN; Suppes T; Mullen JA; Brecher M; Devine NA; Sweitzer DE
Bipolar Disord; 2004 Jun; 6(3):213-23. PubMed ID: 15117400
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate.
Sokolski KN; Denson TF
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):863-6. PubMed ID: 12921920
[TBL] [Abstract][Full Text] [Related]
29. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
[TBL] [Abstract][Full Text] [Related]
30. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
31. Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.
Bobo WV; Reilly-Harrington NA; Ketter TA; Brody BD; Kinrys G; Kemp DE; Shelton RC; McElroy SL; Sylvia LG; Kocsis JH; McInnis MG; Friedman ES; Singh V; Tohen M; Bowden CL; Deckersbach T; Calabrese JR; Thase ME; Nierenberg AA; Rabideau DJ; Schoenfeld DA; Faraone SV; Kamali M
J Affect Disord; 2014 Jun; 161():30-5. PubMed ID: 24751304
[TBL] [Abstract][Full Text] [Related]
32. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).
Weisler RH; Nolen WA; Neijber A; Hellqvist A; Paulsson B;
J Clin Psychiatry; 2011 Nov; 72(11):1452-64. PubMed ID: 22054050
[TBL] [Abstract][Full Text] [Related]
33. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.
Ghaemi SN; Goodwin FK
J Affect Disord; 2001 Aug; 65(3):281-7. PubMed ID: 11511408
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
[TBL] [Abstract][Full Text] [Related]
35. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
Adler CM; Fleck DE; Brecher M; Strakowski SM
J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737
[TBL] [Abstract][Full Text] [Related]
36. A Pilot Study of the Effectiveness of Lithium Versus Quetiapine Immediate Release Monotherapy in Patients With Bipolar Spectrum Disorders.
Gao K; Goto T; Yuan C; Brownrigg B; Conroy C; Chan PK; Serrano MB; Ganocy SJ; Fang F; Calabrese JR
J Clin Psychopharmacol; 2018 Oct; 38(5):422-434. PubMed ID: 30102627
[TBL] [Abstract][Full Text] [Related]
37. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
38. Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.
Suppes T; Kelly DI; Keck PE; McElroy SL; Altshuler LL; Mintz J; Frye MA; Nolen WA; Luckenbaugh DA; Post RM; Leverich GS; Kupka RW; Grunze H
Int Clin Psychopharmacol; 2007 Nov; 22(6):376-81. PubMed ID: 17917557
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
